and functional diversity of skeletal muscles reflects a variety of myosin isoforms. The myosin molecule is composed of two myosin heavy chains (MHCs), the carboxy-terminal portions of which associate to form an a-helical coiled-coil rod (myosin tail), whereas the amino-terminal portions are separated and form two elongated globular domains (myosin heads). At the head-tail junction each MHC associates with two myosin light chains (MLCs), one belonging to the alkali or MLCl family and one to the regulatory or MLCZ family. Both MHCs (mol mass -220 kDa) and MLCs (mol mass 17-23 kDa) exist in multiple isoforms that are differentially distributed in the various fiber types. Our understanding of the complexity of myosin diversity and of the functional significance of MHC and MLC isoforms has rapidly progressed during the last few years. Major advances in the study of mammalian skeletal muscle myosins have been the recognition of a new "fast-type" MHC isoform that is widely distributed in most skeletal muscles, the characterization of the developmental MHC transitions that lead to the emergence of the adult myosin isoform profile, and the demonstration that both MHCs and MLCs influence the velocity of muscle shortening.
muscles of different mammalian species contain four major myosin heavychain (MHC) isoforms: the "slow" or ,&MHC and the three "fast" IIa-, 11x-, and IIb-MHCs;
and three major myosin light-chain (MLC) isoforms, the "slow" MLCls and the two "fast" MLClf and MLC3f. The differential distribution of the MHCs defines four major fiber types containing a single MHC isoform and a number of intermediate hybrid fiber populations containing both ,Wslow-and IIa-MHC, IIa-and 11x-MHC, or 11x-and IIb-MHC. The IIa-, 11x-, and IIb-MHCs were first detected in neonatal muscles, and their expression in developing and adult muscle is regulated by neural, hormonal, and mechanical factors. The transcriptional mechanisms responsible for the fiber type-specific regulation of MHC and MLC gene expression are not known and are presently being explored by in vivo transfection experiments. The functional role of MHC isoforms has been in part clarified by correlated biochemical-physiological studies on single skinned fibers: these studies, in agreement with results from in vitro motility assays, indicate that both MHC and MLC isoforms determine the maximum velocity of shortening of skeletal muscle fibers. myosin heavy chains; myosin light chains; muscle fiber types; muscle fiber differentiation; velocity of muscle shortening THE STRUCTURAL and functional diversity of skeletal muscles reflects a variety of myosin isoforms. The myosin molecule is composed of two myosin heavy chains (MHCs), the carboxy-terminal portions of which associate to form an a-helical coiled-coil rod (myosin tail), whereas the amino-terminal portions are separated and form two elongated globular domains (myosin heads). At the head-tail junction each MHC associates with two myosin light chains (MLCs), one belonging to the alkali or MLCl family and one to the regulatory or MLCZ family. Both MHCs (mol mass -220 kDa) and MLCs (mol mass 17-23 kDa) exist in multiple isoforms that are differentially distributed in the various fiber types. Our understanding of the complexity of myosin diversity and of the functional significance of MHC and MLC isoforms has rapidly progressed during the last few years. Major advances in the study of mammalian skeletal muscle myosins have been the recognition of a new "fast-type" MHC isoform that is widely distributed in most skeletal muscles, the characterization of the developmental MHC transitions that lead to the emergence of the adult myosin isoform profile, and the demonstration that both MHCs and MLCs influence the velocity of muscle shortening.
In this brief review we focus on three major aspects: 1) the fiber type distribution of MHC isoforms in mammalian skeletal muscles and their developmental changes, with particular reference to the "fast" or type II MHCs; 2) the myosin gene families and the regulation of their expression; and 3) the functional role of MHC and MLC variants. Our aim is not to present a comprehensive review of myosin diversity but rather to illustrate recent important advances, discuss open issues, and show the direction of ongoing research. The catalog of myosin isoforms so far identified is still incomplete: most studies have focused on a few muscles of selected mammalian species, and additional myosin variants are probably present in fibers so far considered to be homogeneous in terms of myosin composition (e.g., the slow fibers; see below). On the basis of available information, it is useful to distinguish between major isoforms, which are widely distributed in most muscles and most animal species, and minor isoforms, which have a restricted distribution in specialized muscles. A list of the major MHC and MLC isoforms identified in rat skeletal muscle is shown in mammalian species, such as mouse, guinea pig, and rabbit. The structure of each MHC or MLC isotype is generally conserved between species, whereas greater sequence divergence may be found between different isotypes within the same organism.
Sarcomeric MHCs and MLCs are the product of three multigene families, each presumably derived from a single ancestor gene. The MHC gene family comprises several genes, each coding a distinct isoform, that are located in two clusters. The ,@lslow-MHC gene is closely linked to the cardiac cu-MHC gene on chromosome 14 in both human and mouse (42, 58, 80) . The other skeletal muscle genes, including the embryonic and neonatal (or perinatal) isoforms and the adult fast MHCs, are clustered on human chromosome 17 and mouse chromosome 11 (36, 80) . At least six MHC genes, some of which are still unidentified, are present in the human chromosome 17 cluster (69, 85) . At variance with the MHC genes, the MLC genes are dispersed in different chromosomes. Each sarcomeric MLC is coded by a distinct gene, with the exception of the MLClf and MLC3f isoforms, which originate from a single gene by alternative promoters and alternative splicing of the first exons (for review see Ref. 5) .
The distribution of the various MHC and MLC isoforms is not always strictly confined to specific muscle fibers or specific stages of development. For example, the embryonic and neonatal MHCs persist in adult extraocular muscles (62, 83) and intrafusal nuclear chain fibers (56), as well as in the adult masseter muscle (10, 18), which also contains the embryonic MLCl (68). Embryonic and neonatal MHCs and embryonic MLCl are also reexpressed in regenerating (13, 61) and denervated muscle (65). Furthermore, the MLCs typical of fast muscles can be detected in a number of type I (slow) fibers, and, conversely, MLCs typical of slow muscles are found in some type II (fast) fibers. MHC and MLC isoforms can in fact associate in various combinations, generating a large number of myosin molecules (see Ref. 48) .
In addition to the major isoforms indicated in Table 1 , other MHC and MLC variants have been identified in certain muscles and in certain species. A specific MHC and specific MLCl and MLC2 isoforms have been detected in the fast-contracting jaw-closing muscles and in the tensor timpani muscle of some carnivores and primates (44, 57 (23, 66, 67) . The 11x fibers are not easily distinguished from IIa and IIb fibers by the usual adenosinetriphosphatase (ATPase) histochemical reactions and in previous studies were generally confused with the IIb fibers. The 11x fibers are numerous in most leg muscles and are especially abundant in the diaphragm (66), are rich in oxidative enzymes (67), and belong to motor units relatively resistant to fatigue (34). Immunoblotting analyses showed that muscles rich in 11x fibers contain a 11x-MHC isoform distinct from IIa-and IIb-MHCs (66). Three type II MHC isoforms were independently identified by gel electrophoresis (3). Single-fiber studies showed that the band of intermediate mobility between the IIa-and IIb-MHCs, which is called IId-MHC, is distributed in a specific type II fiber population (72). Because 11x-MHC was also separated and identified by immunoblotting as a band of intermediate electrophoretic mobility (3l), it appears that 11x-and IId-MHCs correspond to the same isoform ( Fig. 1) .
Definitive evidence that the novel MHC is a distinct protein and not the product of posttranslational modification of other MHCs was recently obtained with the isolation of cDNAs corresponding to the specific IIx-MHC mRNA (19 untranslated sequences that can be used to generate specific probes. In situ hybridization studies using these probes show that IIa-, IIb-, and 11x-MHC mRNAs are differentially distributed in the corresponding fiber types identified by staining of serial sections with specific anti-MHC antibodies (Fig. 2 ). In agreement with the results of immunocytochemical (66) and electrophoretic studies (72), in situ hybridization also shows that, in addition to fibers containing a single type of MHC mRNA, there are fibers coexpressing different MHC genes, i.e., fibers containing both p/slow-and IIa-MHC, IIa-and 11x-MHC, or 11x-and IIb-MHC.
These hybrid fibers are very numerous in rat muscles; for example, the extensor digitorum longus muscle contains -26% pure 11x fibers, 10% IIa/ 11x hybrid fibers, and 20% IIx/IIb hybrid fibers (19).
Fibers showing an immunoreactivity profile characteristic of type 11x-MHC are numerous in mouse and guinea pig muscles (23) The development of fast skeletal muscles is accompanied by the progressive substitution of the embryonic. and neonatal MHC isoforms with the adult type II MHC isoforms (82). As discussed above, the appearance of the definitive ,Wslow-MHC is also apparently preceded by two antigenically distinct "slow" isoforms; however, these MHCs have not yet been characterized biochemically (28). A simplified scheme of muscle fiber diversification in rat muscles, based on major and well-documented MHC isoform transitions, is shown in Fig. 3 . The first fetal stage is characterized by the differentiation of fibers strongly expressing ,B/slow-MHC, derived from primary generation fibers, and fibers strongly expressing neonatal MHC, derived from both primary and secondary generation fibers (15, 40, 46) . The appearance of the three type II MHC mRNAs, which are first detected a few days after birth in rat hindlimb muscles, defines a second neonatal phase in muscle fiber differentiation (19). Interestingly, the various mRNAs display since the earliest appearance a specific fiber distribution; for example, many fibers of soleus muscle contain IIa-but not IIxor IIb-MHC transcripts, and many fibers of tibialis anterior contain IIb-but not IIa-or 11x-MHC transcripts, whereas other fibers express 11x-MHC mRNA exclusively. The distribution of the various transcripts prefigures the pattern found in adult muscles. During postnatal development the embryonic and neonatal MHC isoforms are progressively eliminated at various time Muscle fiber diversification is also accompanied by changes in MLC composition during fetal and postnatal development. MLClf and MLClemb are the major transcripts in both developing fast and slow fetal muscles, whereas MLCls transcripts are first detected at relatively later fetal stages and are exclusively expressed in prospective type I fibers, namely, the same fibers showing greater accumulation of P/slow-MHC (40, 46). Postnatal development is characterized by the disappearance of MLClemb, which is accompanied by a progressive increase in MLC3f in fast muscles and a switch from the mixed MLClf/MLCls profile to the pure MLCls profile in slow muscles (43). Electrophoretic analyses on single fibers indicate that MLClf and MLC3f generally coexist within the same type II fibers. In rat skeletal muscles, the relative proportion of the two isoforms is variable but MLC3f is significantly more abundant in IIb than in 11x or IIa fibers, with the lowest concentrations being found in IIa fibers (6, 77).
REGULATION OF FIBER TYPE-SPECIFIC MYOSIN GENE EXPRESSION
Multiple mechanisms, including myoblast predetermination, neuronal influences, and thyroid hormone, regulate muscle fiber diversification and myosin gene expression during development (for review see Ref. 25 Ref. 37) . For example, 11x-MHC can be induced in the rat soleus muscle, in which this isoform is normally absent, by either thyroid hormone treatment, electrical stimulation at high frequency, or mechanical unloading after hindlimb suspension (2, 12, 19). The MHC transitions appear to reflect an obligatory pathway of MHC gene expression in the order I +-+ IIa ++ 11x -IIb (64). Changes in the pattern of activity or in thyroid hormone levels can push the transformation of the fiber phenotype to the right or to the left along this pathway. This interpretation helps to explain the apparently paradoxical finding (30) that the IIa-MHC gene is upregulated by thyroid hormone in the soleus muscle, which contains a majority of type I fibers, but is downregulated in the extensor digitorum longus muscle, which is composed almost exclusively of type II fibers. It remains to be established whether the specific patterns of MHC transitions reflect specific rules in the transcriptional regulation of MHC genes and whether MHC gene regulation is affected by the chromosomal organization of the MHC gene clusters.
The regulatory DNA sequences and the transcription factors responsible for fiber type-specific myosin gene expression are not. known. It has been suggested (29, 76) that the transcription factors MyoD and myogenin, which are known to play a role in muscle cell differentiation during development (for review see Ref. 79) , may be implicated in differential muscle gene expression. MyoD mRNAs are more abundant in type II muscle fibers, whereas myogenin mRNAs are more abundant in type I fibers, and the transformation of fiber types induced by thyroid hormone or by cross-reinnervation is accompanied by a corresponding alteration in the MyoD and myogenin mRNA levels. However, at present there is no direct evidence for a specific role of MyoD and myogenin in the differential regulation of myosin genes in skeletal muscle fibers.
In vitro transfection assays, which are generally used to study muscle gene regulation, are not appropriate to identify fiber type-specific sequences because cultured muscle cells do not undergo fiber type differentiation. On the other hand, in transgenic animals the pattern of transgene expression may differ from that of the corresponding endogenous gene. For example, a transgene made of regulatory sequences of the MLClf/3f gene linked to a bacterial reporter gene is expressed in fast but not in slow muscle fibers like the corresponding endogenous gene. However, at variance with the endogenous gene, the level of expression of the transgene varies according to the type II fiber subtype, in the order IIb > 11x > IIa fibers (20) . Similar variations in level of expression between type II fiber subtypes have been observed with a quail fast troponin I transgene (27). It has been suggested that the IIb > 11x > IIa expression hierarchy may represent a fundamental pattern, also possibly involved in the regulation of MHC genes, whereas additional, as yet unidentified, elements would be responsible for enhancing the expression in 11x and IIa fibers, leading to the homogeneous expression of the endogenous gene in the three type II fiber populations (27) . An alternative interpretation is that the abnormal pattern of expression of these transgenes results from differences in genomic imprinting, possibly due to methylation processes, between transgenes and their endogenous counterparts: genomic imprinting has been implicated in the generation of the aberrant rostrocaudal gradient of MLClf/3f transgene expression (21). It will be of interest to determine whether similar variations in gene expression are seen using alternative procedures of in vivo transfection, such as intramuscular injection of plasmid DNA into skeletal muscles of adult animals (84). The efficiency of gene transfer is very low in normal rat muscles, but the level of expression of the transgene can be increased by two orders of magnitude by DNA injection into regenerating muscles (75). We are presently using this experimental model to identify the regulatory sequences responsible for the fiber type-specific expression of muscle genes. In a recent study plasmids containing fragments of the Y-flanking region of the mouse MLCls gene linked to bacterial reporter genes showed a much higher level of expression in slow than in fast muscles, like the corresponding endogenous gene, and a specific regulatory element has been identified by deletion analysis in the MLCls gene promoter (74). Since the early studies of Close (14) and Barany (4), the maximum velocity of shortening of fast and slow skeletal muscles has been correlated with the presence of myosin isozymes having high and low ATPase activity, respectively. The higher efficiency in chemomechanical conversion of the slow myosin isozymes has been considered responsible for the greater economy in tension maintainance of slow muscles compared with fast muscles (see Ref. 16) . Subsequent studies have shown that shortening velocity may also differ between muscles containing different fast-type myosins. For example, the rat extensor digitorum longus muscle, containing predominantly IIb-MHC, has a higher maximum shortening velocity than the soleus muscle chronically stimulated at high frequency, which contains predominantly 11x-MHC (63). However, interpretation of studies at the whole muscle level is complicated by the heterogeneous composition of most skeletal muscles. Single-fiber studies have shown that the presence of slow MHCs and MLCs is correlated with a lower shortening velocity, a lower power output, and a higher curvature of the force-velocity relationship than fast myosin isoforms (9, 24, 54, 71) . The relative role of the MHC and MLC isoforms in determining these differences has not been clearly established. MHC isoforms have been considered as major determinants of the different speed of fast and slow muscle fibers (54); however, MLCs may be important as well, as suggested by the finding that human type IIa fibers that contain exclusively MLCZf have a higher shortening velocity than hybrid IIa fibers containing both MLCZf and MLC2s (35) .
The functional role of fast-type MHC and MLC isoforms has been investigated in a number of correlated biochemical-physiological studies on mammalian single fibers. Fibers containing IIa-MHC were found to display a lower maximum velocity of shortening than fibers containing 22, 35, 55, 71) . Fibers containing 11x-MHC are more similar to IIa fibers with respect to shortening velocity, whereas they are similar to IIb fibers with respect to power output and curvature of the forcevelocity curve (9). On the other hand, a role of the alkali MLCs was suggested by the finding that the maximum velocity of shortening is higher in fibers that contain higher amounts of MLC3f (22, 24, 71) . Interpretation of these results is complicated by the preferential association of MLClf with IIa-MHC and MLC3f with 41, 60, 77) . Therefore it is not clear whether IIb fibers are faster because they contain IIb-MHC or because they contain more MLC3f. The relative role of MHC and MLC isoforms can only be established by comparing the contractile properties of fibers containing the same MHC isoform but differing in MLC3f relative content or in fibers with similar MLC3f content but different MHC isoform composition. This has been done in two recent studies on single human (35) and rat muscle fibers (6). By using rat muscle fibers containing a single type of MHC, and thus avoiding the further complication of the coexistence of multiple MHCs (7), Bottinelli et al. (6) found that the maximum shortening velocity is closely related to the relative content of MLC3f. This finding is in agreement with previous results in skinned fibers in which MLClf was partially substituted with MLC3f (45). However, as shown in Fig. 4 , the impact of MLC3f is more pronounced in IIb fibers, where a 10% variation in MLC3f content gives a 16% change in maximum shortening velocity, than in IIa and 11x fibers, where the same 10% variation induces a 4 and 8% change, respectively, of the mechanical parameters. Thus it appears that in rat muscle fibers both MHCs and alkali MLCs determine the maximum shortening velocity: at a given value of MLC3f relative content, velocity depends on MHC composition, and vice versa. On the other hand, Larsson and Moss (35) were not able to find any correlation between maximum shortening velocity and MLC3f relative content in human muscle fibers. However, as suggested by the same authors, interpretation of these results is complicated by the frequent coexistence of fast and slow MLC2 isoforms in a large proportion of type II human fibers and the aforementioned possible influence of MLC2 isoforms in determining the maximum shortening velocity.
The alkali MLC isoform composition does not seem to play a correspondingly important role in the ATP consumption and economy of tension development of isometrically contracting fast fibers. As shown in Fig. 5A , during isometric contraction the ATPase activity is significantly higher in rat type II than in type I fibers and, among type II fibers, in fibers containing IIb-MHC than in fibers containing IIa-or 11x-MHC (8). However, no significant relationship was observed between ATPase activity and the relative proportion of MLC3f (Fig. 5B ). This conclusion is in agreement with the results of studies on avian fast myosins: the actin-activated ATPase activity of myosin from chicken pectoralis muscle is only little decreased by removal of alkali MLCs (38), and no significant difference in ATPase activity is found between two myosin fractions containing either MLClf or MLC3f (47). Lowey et al. (38, 39) have also explored the functional role of MLCs using an in vitro motility assay, i.e., a reconstituted actomyosin system made of fluorescent actin filaments sliding over chicken pectoralis myosin adhered to nitrocellulose-coated coverslips. The velocity of actin filaments, which can be considered an analogue of unloaded velocity of shortening of muscle, is markedly decreased by removal of MLCs (38) and is significantly higher in myosin containing MLC3f than in myosin containing MLClf (39). Using the same approach it was found that myosins from embryonic and early posthatch chicken pectoralis, which contain similar MLC complement but different MHCs, translocate actin at different velocities, suggesting that the heavy chain is the principal determinant of the lower velocity of embryonic compared with neonatal and of neonatal compared with adult muscle myosin (39).
In conclusion, it appears that both MHC and MLC isoforms are responsible for determining the maximum velocity of shortening, whereas only MHCs determine the ATP consumption and the isometric tension cost. This conclusion is consistent with current molecular models of muscle contraction based on a variety of biochemical and biophysical approaches and confirmed by the recent crystallographic reconstruction of the myosin Sl subfragment (52, 53) . The structural model clearly shows that the ATPase site and the actin binding region are located on opposite sides of the distal globular part of the myosin head, which represents the motor domain. This domain undergoes small conformational changes in relation to the hydrolytic cycle; these changes are amplified and transmitted to the thick filament through a 85-A-long a-helix, around which are wrapped the regulatory and alkali MLCs (light-chain binding domain). Within the framework of the new structural information, one can now ask specific questions concerning the properties of the various myosin isoforms. I) Which sequences of the MHC are critical for the molecular events that determine the speed of movement or the ATPase hydrolysis rate? 2) Is the lower shortening velocity associated with MLClf due to changes in the physical properties of the 85-A MHC a-helix (possibly caused by the long aminoterminal extension of MLClf) or to a direct interaction between MLClf and actin that could place a mechanical load on the cycling cross bridges? Several converging lines of research, including molecular biology studies providing the complete sequence of various MHCs, crystallographic studies, and in vitro motility assays with recombinant normal and mutated MHCs and MLCs, should contribute to answering these and similar questions and to further progress in defining the functional role of the different myosin isoforms present in mammalian skeletal muscle. A., C. Janmot, and J.-J. Bechet.
